BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 Generation of functional multipotent adult stem cells from GPR125+ germline progenitors.
16 auth. M. Seandel, D. James, S. Shmelkov, Ilaria Falciatori, Jiyeon Kim, S. Chavala, D. Scherr, Fan Zhang, R. Torres, N. Gale, ... G. Yancopoulos, A. Murphy, D. Valenzuela, R. Hobbs, P. Pandolfi, S. Rafii
8 2007
8
🐜
🐜 Urothelial carcinoma of the bladder and the upper tract: disparate twins.
9 auth. David A. Green, M. Rink, E. Xylinas, S. Matin, A. Stenzl, M. RouprΓͺt, ... P. Karakiewicz, D. Scherr, S. Shariat
8 2013
8
🐜
🐒 Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy
Gerald J. Wang, D. Barocas, J. Raman, D. Scherr
8 2007
8
🐒
🐜 Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
33 auth. K. Ahmed, S. Khan, M. Hayn, P. Agarwal, K. Badani, M. Balbay, E. Castle, P. Dasgupta, R. Ghavamian, K. Guru, A. Hemal, B. Hollenbeck, A. Kibel, M. Menon, A. Mottrie, ... K. Nepple, J. Pattaras, J. Peabody, V. Poulakis, R. Pruthi, J. Redorta, K. Rha, L. Richstone, M. Saar, D. Scherr, S. Siemer, M. Stoeckle, E. Wallen, A. Weizer, P. Wiklund, T. Wilson, M. Woods, Muhammad Shamim Khan
7 2014
7
🐜
🐜 Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
27 auth. E. Xylinas, M. Rink, E. Cha, T. Clozel, R. Lee, H. Fajkovic, E. Comploj, G. Novara, V. Margulis, J. Raman, Y. Lotan, W. Kassouf, H. Fritsche, A. Weizer, J. MartΓ­nez-Salamanca, ... Kazumasa Matsumoto, R. Zigeuner, A. Pycha, D. Scherr, C. Seitz, T. Walton, Q. Trinh, P. Karakiewicz, S. Matin, F. Montorsi, M. Zerbib, S. Shariat
7 2014
7
🐜
🐜 Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.
13 auth. S. Salami, F. Schmidt, B. Laxman, M. Regan, D. Rickman, D. Scherr, Gerardina Bueti, J. Siddiqui, S. Tomlins, John T. Wei, ... A. Chinnaiyan, M. Rubin, M. Sanda
7 2013
7
🐜
🐜 Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder
16 auth. E. Xylinas, M. Kent, L. Kluth, L. Kluth, A. Pycha, E. Comploj, R. Svatek, Y. Lotan, Q. Trinh, P. Karakiewicz, ... S. HolmΓ€ng, D. Scherr, M. Zerbib, A. Vickers, S. Shariat, S. Shariat
7 2013
7
🐜
🐜 Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma.
14 auth. James C. Brien, S. Shariat, M. Herman, C. Ng, D. Scherr, B. Scoll, R. Uzzo, Mark A. Wille, S. Eggener, J. Terrell, ... S. Lucas, Y. Lotan, S. Boorjian, J. Raman
7 2010
7
🐜
🐜 Urinary cytology has a poor performance for predicting invasive or high‐grade upper‐tract urothelial carcinoma
16 auth. J. Messer, S. Shariat, James C. Brien, Mitchell P. Herman, C. Ng, D. Scherr, B. Scoll, R. Uzzo, Mark A. Wille, S. Eggener, ... G. Steinberg, J. Terrell, S. Lucas, Y. Lotan, S. Boorjian, J. Raman
7 2011
7
🐜
🐜 Complications after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
26 auth. Raza Johar, M. Hayn, Andrew Stegemann, K. Ahmed, P. Agarwal, M. Balbay, A. Hemal, A. Kibel, F. Muhletaler, K. Nepple, J. Pattaras, J. Peabody, J. Palou Redorta, K. Rha, L. Richstone, ... M. Saar, F. Schanne, D. Scherr, S. Siemer, Michael StΓΆkle, A. Weizer, P. Wiklund, T. Wilson, M. Woods, Bertrum Yuh, K. Guru
7 2013
7
🐜
🐬 Increased Expression of the Polycomb Group Gene, EZH2, in Transitional Cell Carcinoma of the Bladder
J. Raman, N. Mongan, S. Tickoo, S. Boorjian, D. Scherr, L. Gudas
7 2005
7
🐬